http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102924603-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19 |
| filingDate | 2011-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102924603-B |
| titleOfInvention | The fusion rotein of human interferon and targeting peptides and preparation thereof |
| abstract | The invention provides fusion rotein and the preparation thereof of human interferon and targeting peptides, fusion rotein of the present invention, its structure is: IFN-M-S, wherein S represents targeting peptides, and M represents connection peptides, and IFN represents Interferon, rabbit, S aminoacid sequence can be in S1, S2, S3, S4 any one, M aminoacid sequence contains 0-10 amino-acid residue, a preferred 4-6 amino-acid residue, and IFN can be any one in I type and II type Interferon, rabbit. |
| priorityDate | 2011-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 114.